This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Percent of patients with hematocrit 33 or greater or hemoglobin 11 or greater
National Measure Source
Centers for Medicare and Medicaid Services (CMS), End Stage Renal Disease (ESRD) Clinical Performance Measures Project.
1.31a Percent of hemodialysis patients with hemoglobin 11 gm/dL or higher, United States, 2002 and 2003.
National Data Source
CMS, ESRD Clinical Performance Measures Project.
Medicare adult (age 18 and over) in-center hemodialysis (HD) patients or peritoneal dialysis (PD) patients, exclude patients with mean hemoglobin of 12g/dL or greater who are not prescribed Epoetin at any time during the study period (HD patients: October to December, PD patient: January to March).
Subset of the denominator population with mean hemoglobin of 11g/dL or higher during the study period.
State Measure Source
University of Michigan Kidney Epidemiology and Cost Center, Unit Specific Report.
1.31b Percent of patients with hematocrit 33 or greater, by State, 2000 and 2003.
State Data Source
Data from the 2003 unit-specific report for dialysis patients, University of Michigan Kidney Epidemiology and Cost Center.
Medicare dialysis patients.
Subset of the denominator population with hematocrit 33 or greater.